tetano
Editor, Senior Moderator
Cureus
. 2021 Aug 1;13(8):e16817.
doi: 10.7759/cureus.16817. eCollection 2021 Aug.
Impact of COVID-19 on Thrombus Burden and Outcome in Acute Myocardial Infarction
Bhagya N Pandit[SUP] 1 [/SUP], Abhinav Shrivastava[SUP] 1 [/SUP], Ranjit K Nath[SUP] 1 [/SUP], Dheerendra Kuber[SUP] 1 [/SUP], Santosh K Sinha[SUP] 2 [/SUP], Puneet Aggarwal[SUP] 1 [/SUP]
Affiliations
Abstract
Background Cardiovascular manifestations are one of the most common complications in coronavirus disease 2019 (COVID-19) infection and are associated with increased mortality. However, the impact of COVID-19 infection on thrombus burden and the outcome of acute myocardial infarction (AMI) has not been studied. Methods This was a retrospective, observational study that included all adult patients (>18 years) diagnosed with AMI with or without COVID-19 infection. Epidemiological, laboratory, clinical, interventional, and outcome data were extracted and the impact of COVID-19 on thrombus burden and the primary clinical composite endpoint of all-cause death during hospital admission or 30 days after discharge was studied. Results The study population included 336 patients, including 56 patients with COVID and AMI and 280 patients with AMI without COVID-19 infection. Chest pain was the most common symptom (84.8%) while one or more co-morbidity was present in 117 (34.8%) patients. Forty-eight patients in the AMI with COVID group had ST-segment elevation myocardial infarction (STEMI) while 256 patients in the AMI without COVID group had STEMI, eight patients in the AMI with COVID group had non-ST-segment elevation myocardial infarction (NSTEMI), and 24 in the AMI without COVID group had NSTEMI. Patients with COVID-19 co-infection had a higher thrombus burden as compared to the patients without COVID-19 AMI group (p-value 0.008). The primary outcome in the form of all-cause mortality was seen in 13 (3.9%) patients, which was also more in the AMI with COVID group. Conclusion COVID-19 in AMI is a state of high thrombus burden associated with higher mortality, especially in patients with chronic co-morbidities.
Keywords: acute myocardial infarction; coronary thrombus; covid-19; percutaneous coronary intervention; st-elevation myocardial infarction (stemi).
. 2021 Aug 1;13(8):e16817.
doi: 10.7759/cureus.16817. eCollection 2021 Aug.
Impact of COVID-19 on Thrombus Burden and Outcome in Acute Myocardial Infarction
Bhagya N Pandit[SUP] 1 [/SUP], Abhinav Shrivastava[SUP] 1 [/SUP], Ranjit K Nath[SUP] 1 [/SUP], Dheerendra Kuber[SUP] 1 [/SUP], Santosh K Sinha[SUP] 2 [/SUP], Puneet Aggarwal[SUP] 1 [/SUP]
Affiliations
- PMID: 34522477
- PMCID: PMC8425106
- DOI: 10.7759/cureus.16817
Abstract
Background Cardiovascular manifestations are one of the most common complications in coronavirus disease 2019 (COVID-19) infection and are associated with increased mortality. However, the impact of COVID-19 infection on thrombus burden and the outcome of acute myocardial infarction (AMI) has not been studied. Methods This was a retrospective, observational study that included all adult patients (>18 years) diagnosed with AMI with or without COVID-19 infection. Epidemiological, laboratory, clinical, interventional, and outcome data were extracted and the impact of COVID-19 on thrombus burden and the primary clinical composite endpoint of all-cause death during hospital admission or 30 days after discharge was studied. Results The study population included 336 patients, including 56 patients with COVID and AMI and 280 patients with AMI without COVID-19 infection. Chest pain was the most common symptom (84.8%) while one or more co-morbidity was present in 117 (34.8%) patients. Forty-eight patients in the AMI with COVID group had ST-segment elevation myocardial infarction (STEMI) while 256 patients in the AMI without COVID group had STEMI, eight patients in the AMI with COVID group had non-ST-segment elevation myocardial infarction (NSTEMI), and 24 in the AMI without COVID group had NSTEMI. Patients with COVID-19 co-infection had a higher thrombus burden as compared to the patients without COVID-19 AMI group (p-value 0.008). The primary outcome in the form of all-cause mortality was seen in 13 (3.9%) patients, which was also more in the AMI with COVID group. Conclusion COVID-19 in AMI is a state of high thrombus burden associated with higher mortality, especially in patients with chronic co-morbidities.
Keywords: acute myocardial infarction; coronary thrombus; covid-19; percutaneous coronary intervention; st-elevation myocardial infarction (stemi).